Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Serine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.50 |
| ▸ | GLUL | P15104 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.45 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL192645 | 1.00 | SLC1A1 (0.50) | SLC1A1GLULPTGS1SLC7A11GRM8 | |
| Serine SCHEMBL17927566 | 1.00 | SLC1A1 (0.50) | SLC1A1GLULPTGS1SLC7A11GRM8 | |
| Serine SCHEMBL27765657 | 0.97 | SLC1A1 (0.48) | SLC1A1GLULPTGS1SLC7A11GRM8 | |
| Serine SCHEMBL17187316 | 0.92 | SLC1A1 (0.48) | SLC1A1GLULPTGS1SLC7A11GRM8 | |
| Serine SCHEMBL9167560 | 0.90 | PTGS1 (0.48) | SLC1A1GLULPTGS1SLC7A11GRM8 | |
| Serine SCHEMBL1332181 | 0.89 | — | — | |
| Serine SCHEMBL6929773 | 0.89 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11GRM8GRM6 | |
| (D)-Serine SCHEMBL43094 | 0.89 | — | — | |
| (D)-Serine SCHEMBL6660617 | 0.89 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11GRM8GRM6 | |
| Serine SCHEMBL6520912 | 0.89 | SLC1A1 (0.59) | SLC1A1PTGS1SLC7A11GRM8GRM6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075784-A | Bionic bone with controllable solidification time and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-115397247-B | Fermented milk, process for producing the same, and dephosphorized yogurt | GODO SHUSEI Co.,Ltd. (JP) | 2026-05-26 | — | — | CN | claimed |
| CN-120078927-A | High-strength low-immune-response bone adhesive material and preparation and application methods thereof | 杭州源囊生物科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-115804861-B | Bone adhesive solid phase composition and bone adhesive | 北京纳通医学研究院有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117338992-A | Bone adhesive and preparation method thereof | 上海瑞凝生物科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-113624862-B | Metabolome covering multiple metabolites, metabolic flux analysis method and kit | 清华大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115804861-A | Bone adhesive solid-phase composition and bone adhesive | 北京纳通医学研究院有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-109640633-A | Plant, the manufacturing method of plant, resistance adding method, tomato and tomato manufacturing method | 积水化学工业株式会社 | 2019-04-16 | — | — | CN | claimed |
| CN-108201635-A | Bone Defect Repari stent under a kind of articular cartilage | 重庆润泽医药有限公司 | 2018-06-26 | — | — | CN | claimed |
| CN-104643067-B | Nutritional emulsions comprising HMB calcium and soluble protein | 雅培制药有限公司 | 2018-02-06 | — | — | CN | claimed |
| CN-103025360-A | Reinforced adhesive complex coacervates and methods of making and using thereof | UNIV UTAH RES FOUND | 2013-04-03 | — | — | CN | claimed |
| CN-102762112-A | Plastic packaged nutritional liquids comprising HMB | ABBOTT LAB | 2012-10-31 | — | — | CN | claimed |
| CN-102711522-A | Aseptically packaged nutritional liquids comprising HMB | ABBOTT LAB | 2012-10-03 | — | — | CN | claimed |
| CN-102711525-A | Nutritional emulsions comprising calcium HMB and soluble protein | ABBOTT LAB | 2012-10-03 | — | — | CN | claimed |
| CN-102711524-A | Nutritional emulsions comprising calcium hmb | ABBOTT LAB | 2012-10-03 | — | — | CN | claimed |
| CN-101978040-A | Adhesive complex coacervates and methods of making and using the same | UNIV UTAH RES FOUDATION (US) | 2011-02-16 | — | — | CN | claimed |
| US-20040180381-A1 | Method for determining amino acid sequence of a peptide | SHIMADZU CORPORATION (JP) | 2004-09-16 | — | — | US | claimed |
| EP-1361872-A4 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS | UNIV VIRGINIA (US) | 2004-05-19 | — | — | EP | claimed |
| EP-1361872-A2 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2003-11-19 | — | — | EP | claimed |
| WO-2002029001-A2 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF VIRGINIAN PATENT FOUNDATION (US) | 2002-04-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180381-A1 | Method for determining amino acid sequence of a peptide | VIP, ANPEP, DNPEP | SLC1A1 910/4885GLUL 218/4885PTGS1 4440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.